Provided by Tiger Trade Technology Pte. Ltd.

Matinas BioPharma Holdings, Inc

2.64
+0.22009.09%
Post-market: 2.870.2300+8.71%19:53 EDT
Volume:295.50K
Turnover:775.48K
Market Cap:2.59M
PE:-0.15
High:2.75
Open:2.53
Low:2.42
Close:2.42
52wk High:29.55
52wk Low:2.26
Shares:979.52K
Float Shares:773.37K
Volume Ratio:1.31
T/O Rate:38.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.8811
EPS(LYR):-30.0000
ROE:-141.23%
ROA:-56.17%
PB:1.44
PE(LYR):-0.09

Loading ...

Matinas Biopharma Says Warrant Exercise Brings in About $2.6 Million Cash Proceeds

Reuters
·
Jul 13

Matinas Biopharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell Lnc Platform Technology and Lead Product Candidate Mat2203 to Azurity Pharmaceuticals

THOMSON REUTERS
·
Jul 13

Matinas Biopharma Holdings - GH Power Equityholders to Own 91% and Matinas Equityholders 9% of Ghp International Post-closing

THOMSON REUTERS
·
Jul 13

Matinas Biopharma Holdings - Each Matinas Common Share to be Converted into 0.1 Ghp International Common Share

THOMSON REUTERS
·
Jul 13

Matinas Biopharma- Proposed Deal for $4.0 Mln Upfront, up to an Additional $17.5 Mln in Potential Milestones and Future Mid-single-digit Royalties

THOMSON REUTERS
·
Jul 13

Matinas BioPharma receives noncompliance notification from NYSE

TIPRANKS
·
Jun 27

Matinas Biopharma Gets NYSE American Notice for Failing Stockholders’ Equity Listing Standard

Reuters
·
Jun 27

Matinas Biopharma Receives Notice of Non-compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

THOMSON REUTERS
·
Jun 27

Matinas BioPharma Files $150 Million Mixed Shelf Registration

MT Newswires Live
·
Jun 17

Matinas BioPharma files $150M mixed securities shelf

TIPRANKS
·
Jun 17

BRIEF-Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing

Reuters
·
Jun 17

Matinas BioPharma - May Offer Securities up to $150 Mln - SEC Filing

THOMSON REUTERS
·
Jun 17

Matinas BioPharma Hldgs Q1 EPS $(0.30) Up From $(0.33) YoY

Benzinga Earnings
·
May 09

Matinas BioPharma Q1 net loss widens to $1.92 million

Reuters
·
May 09

Matinas BioPharma receives NYSE American noncompliance notice over listing standards

Reuters
·
Apr 04

Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY

Benzinga Earnings
·
Apr 01

Matinas BioPharma FY25 net loss narrows to $10.3 million

Reuters
·
Apr 01